Global Immuno-Oncology Diagnosis Market By Product & Service (Consumables, Instruments, Software), By Technology (PCR, NGS, Immunoassay), By Cancer Indications (Lung, Breast, Colorectal, Bladder, Melanoma), By Application (Research, Diagnostic), By Region, and Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2021-2031
- Published date: Jan 2022
- Report ID: 74618
- Number of Pages: 312
- Format:
- keyboard_arrow_up
- 1.Immuno-Oncology Diagnosis Market Introduction
- 1.1.Definition
- 1.2.Taxonomy
- 1.3.Research Scope
- 2.Executive Summary
- 2.1.Key Findings by Major Segments
- 2.2.Top strategies by Major Players
- 3.Global Immuno-Oncology Diagnosis Market Overview
- 3.1.Immuno-Oncology Diagnosis Market Dynamics
- 3.1.1.Drivers
- 3.1.2.Opportunities
- 3.1.3.Restraints
- 3.1.4.Challenges
- 3.2.COVID-19 Impact Analysis
- 3.3.COVID-19 Impact Analysis in Global Immuno-Oncology Diagnosis Market
- 3.4.PESTLE Analysis
- 3.5.Opportunity Map Analysis
- 3.6.PORTER'S Five Forces Analysis
- 3.7.Market Competition Scenario Analysis
- 3.8.Product Life Cycle Analysis
- 3.9.Opportunity Orbits
- 3.10.Manufacturer Intensity Map
- 3.11.Major Companies sales by Value & Volume
- 3.1.Immuno-Oncology Diagnosis Market Dynamics
- 4.Global Immuno-Oncology Diagnosis Market Value (US$ Mn), Share (%), and Growth Rate (%) Comparison by Product & Service, 2016-2032
- 4.1.Global Immuno-Oncology Diagnosis Market Analysis by Product & Service: Introduction
- 4.2.Market Size and Forecast by Region
- 4.3.Consumables
- 4.4.Instruments
- 4.5.Software
- 5.Global Immuno-Oncology Diagnosis Market Value (US$ Mn), Share (%), and Growth Rate (%) Comparison by Technology, 2016-2032
- 5.1.Global Immuno-Oncology Diagnosis Market Analysis by Technology: Introduction
- 5.2.Market Size and Forecast by Region
- 5.3.PCR
- 5.4.NGS
- 5.5.Immunoassay
- 6.Global Immuno-Oncology Diagnosis Market Value (US$ Mn), Share (%), and Growth Rate (%) Comparison by Cancer Indications, 2016-2032
- 6.1.Global Immuno-Oncology Diagnosis Market Analysis by Cancer Indications: Introduction
- 6.2.Market Size and Forecast by Region
- 6.3.Lung
- 6.4.Breast
- 6.5.Colorectal
- 6.6.Bladder
- 6.7.Melanoma
- 7.Global Immuno-Oncology Diagnosis Market Value (US$ Mn), Share (%), and Growth Rate (%) Comparison by Application, 2016-2032
- 7.1.Global Immuno-Oncology Diagnosis Market Analysis by Application: Introduction
- 7.2.Market Size and Forecast by Region
- 7.3.Research
- 7.4.Diagnostic
- 8.Global Immuno-Oncology Diagnosis Market Value (US$ Mn), Share (%), and Growth Rate (%) Comparison by Region, 2016-2032
- 8.1.North America
- 8.1.1.North America Immuno-Oncology Diagnosis Market: Regional Trend Analysis
- 8.1.1.1.U.S.
- 8.1.1.2.Canada
- 8.1.1.3.Mexico
- 8.1.1.North America Immuno-Oncology Diagnosis Market: Regional Trend Analysis
- 8.2.1.Europe
- 8.2.1.Europe Immuno-Oncology Diagnosis Market: Regional Trend Analysis
- 8.2.1.1.U.K.
- 8.2.1.2.Germany
- 8.2.1.3.France
- 8.2.1.4.Spain
- 8.2.1.5.Italy
- 8.2.1.6.Russia
- 8.2.1.7.Rest of Europe
- 8.2.1.Europe Immuno-Oncology Diagnosis Market: Regional Trend Analysis
- 8.3.Asia-Pacific
- 8.3.1.Asia-Pacific Immuno-Oncology Diagnosis Market: Regional Trend Analysis
- 8.3.1.1.China
- 8.3.1.2.Japan
- 8.3.1.3.South Korea
- 8.3.1.4.India
- 8.3.1.5.ASEAN
- 8.3.1.6.Rest of Asia-Pacific
- 8.3.1.Asia-Pacific Immuno-Oncology Diagnosis Market: Regional Trend Analysis
- 8.4.Latin America
- 8.4.1.Latin America Immuno-Oncology Diagnosis Market: Regional Trend Analysis
- 8.4.1.1.Brazil
- 8.4.1.2.Argentina
- 8.4.1.3.Rest of Latin America
- 8.4.1.Latin America Immuno-Oncology Diagnosis Market: Regional Trend Analysis
- 8.5.Middle East and Africa
- 8.5.1.Middle East and Africa Immuno-Oncology Diagnosis Market: Regional Trend Analysis
- 8.5.1.1.GCC
- 8.5.1.2.Israel
- 8.5.1.3.South Africa
- 8.5.1.4.Rest of MEA
- 8.5.1.Middle East and Africa Immuno-Oncology Diagnosis Market: Regional Trend Analysis
- 8.1.North America
- 9.Global Immuno-Oncology Diagnosis Market Competitive Landscape, Market Share Analysis, and Company Profiles
- 9.1.Market Share Analysis
- 9.2.Company Profiles
- 9.3.Thermo Fisher Scientific Inc.
- 9.3.1.Company Overview
- 9.3.2.Financial Highlights
- 9.3.3.Product Portfolio
- 9.3.4.SWOT Analysis
- 9.3.5.Key Strategies and Developments
- 9.4.Hoffmann-La Roche Ltd.
- 9.4.1.Company Overview
- 9.4.2.Financial Highlights
- 9.4.3.Product Portfolio
- 9.4.4.SWOT Analysis
- 9.4.5.Key Strategies and Developments
- 9.5.Agilent Technologies Inc.
- 9.5.1.Company Overview
- 9.5.2.Financial Highlights
- 9.5.3.Product Portfolio
- 9.5.4.SWOT Analysis
- 9.5.5.Key Strategies and Developments
- 9.6.Illumina Inc.
- 9.6.1.Company Overview
- 9.6.2.Financial Highlights
- 9.6.3.Product Portfolio
- 9.6.4.SWOT Analysis
- 9.6.5.Key Strategies and Developments
- 9.7.Merck Millipore
- 9.7.1.Company Overview
- 9.7.2.Financial Highlights
- 9.7.3.Product Portfolio
- 9.7.4.SWOT Analysis
- 9.7.5.Key Strategies and Developments
- 9.8.NanoString Technologies
- 9.8.1.Company Overview
- 9.8.2.Financial Highlights
- 9.8.3.Product Portfolio
- 9.8.4.SWOT Analysis
- 9.8.5.Key Strategies and Developments
- 9.9.Sartorius AG
- 9.9.1.Company Overview
- 9.9.2.Financial Highlights
- 9.9.3.Product Portfolio
- 9.9.4.SWOT Analysis
- 9.9.5.Key Strategies and Developments
- 9.10.HTG Molecular Diagnostics Inc.
- 9.10.1.Company Overview
- 9.10.2.Financial Highlights
- 9.10.3.Product Portfolio
- 9.10.4.SWOT Analysis
- 9.10.5.Key Strategies and Developments
- 9.11.QIAGEN N.V.
- 9.11.1.Company Overview
- 9.11.2.Financial Highlights
- 9.11.3.Product Portfolio
- 9.11.4.SWOT Analysis
- 9.11.5.Key Strategies and Developments
- 9.12.Invivoscribe Inc.
- 9.12.1.Company Overview
- 9.12.2.Financial Highlights
- 9.12.3.Product Portfolio
- 9.12.4.SWOT Analysis
- 9.12.5.Key Strategies and Developments
- 9.13.Guardant Health Inc.
- 9.13.1.Company Overview
- 9.13.2.Financial Highlights
- 9.13.3.Product Portfolio
- 9.13.4.SWOT Analysis
- 9.13.5.Key Strategies and Developments
- 10.Assumptions and Acronyms
- 11.Research Methodology
- 12.Contact
- 1.Immuno-Oncology Diagnosis Market Introduction
- Thermo Fisher Scientific Company Profile
- Hoffmann-La Roche Ltd.
- Agilent Technologies Inc. Company Profile
- Illumina Inc.
- Merck Millipore
- NanoString Technologies
- Sartorius AG
- HTG Molecular Diagnostics Inc.
- QIAGEN N.V.
- Invivoscribe Inc.
- Guardant Health Inc.
- Nestlé S.A Company Profile
- settingsSettings
Our Clients
- 74618
- Jan 2022
-
US $5,999US $2,999
-
US $7,999US $3,499
-
US $12,999US $4,499
✖
Request a Sample Report
We'll get back to you as quickly as possible|
Single User
$5,999
$2,999
USD / per unit
save 50% |
Multi User
$7,999
$3,499
USD / per unit
save 55% |
Corporate User
$12,999
$4,499
USD / per unit
save 65% | |
|---|---|---|---|
| e-Access | |||
| Data Set (Excel) | |||
| Company Profile Library Access | |||
| Interactive Dashboard | |||
| Free Custumization | No | up to 10 hrs work | up to 30 hrs work |
| Accessibility | 1 User | 2-5 User | Unlimited |
| Analyst Support | up to 20 hrs | up to 40 hrs | up to 50 hrs |
| Benefit | Up to 20% off on next purchase | Up to 25% off on next purchase | Up to 30% off on next purchase |
| Buy Now ($ 2,999) | Buy Now ($ 3,499) | Buy Now ($ 4,499) |
